Café

TSHA

5.8754.72%( +0.265 )

LongbridgeAI

TSHA

5.8754.72%( +0.265 )

Taysha Gene Therapies Announces Multiple Presentations Highlighting TSHA-102 Program In Clinical Evaluation For Rett Syndrome At 2026 IRSF Rett Syndrome Scientific Meeting

benzinga_article

Jun 25, 2026 at 03:02 PM

Taysha Gene Therapies Announces Multiple Presentations Highlighting TSHA-102 Program In Clinical Evaluation For Rett Syndrome At 2026 IRSF Rett Syndrome Scientific Meeting

Source: benzinga_article The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Taysha Gene Therapies

TSHA.US

Open

High

Low

Prev Close

P/E^TTM

Market Cap

LongbridgeAI

Taysha Gene Therapies Announces Multiple Presentations Highlighting TSHA-102 Program In Clinical Evaluation For Rett Syndrome At 2026 IRSF Rett Syndrome Scientific Meeting

benzinga_article

Jun 25, 2026 at 03:02 PM

Taysha Gene Therapies Announces Multiple Presentations Highlighting TSHA-102 Program In Clinical Evaluation For Rett Syndrome At 2026 IRSF Rett Syndrome Scientific Meeting

Source: benzinga_article The copyright of this article belongs to the original author/organization.

Taysha Gene Therapies

TSHA.US

Open

High

Low

Prev Close

P/E^TTM

Market Cap